Skip to main content

Gain Therapeutics, Inc.

GANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001819411

No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.

13F holders, Q1 2024

Institutional positions in Gain Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
26
+3 vs. Q4 2023
Shares held
1.87M
+910.8K (+95.2%) vs. Q4 2023
Total value
$7.04M
+$3.92M (+125.3%) vs. Q4 2023
New holders
6
10 more added
Sold out
3
6 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 26 institutions
Q1 2021: 12 institutionsQ2 2021: 14 institutionsQ3 2021: 14 institutionsQ4 2021: 19 institutionsQ1 2022: 16 institutionsQ2 2022: 16 institutionsQ3 2022: 23 institutionsQ4 2022: 21 institutionsQ1 2023: 22 institutionsQ2 2023: 24 institutionsQ3 2023: 24 institutionsQ4 2023: 24 institutionsQ1 2024: 26 institutionsQ2 2024: 28 institutionsQ3 2024: 19 institutionsQ4 2024: 25 institutionsQ1 2025: 33 institutionsQ2 2025: 35 institutionsQ3 2025: 38 institutionsQ4 2025: 48 institutionsQ1 2026: 42 institutionsQ2 2026: 50 institutions
Value heldQ1 2024: $7.04M
Q1 2021: $15.0MQ2 2021: $8.95MQ3 2021: $6.65MQ4 2021: $5.71MQ1 2022: $4.75MQ2 2022: $3.87MQ3 2022: $3.95MQ4 2022: $3.78MQ1 2023: $5.54MQ2 2023: $5.68MQ3 2023: $4.95MQ4 2023: $5.05MQ1 2024: $7.04MQ2 2024: $3.89MQ3 2024: $2.40MQ4 2024: $3.94MQ1 2025: $5.07MQ2 2025: $6.49MQ3 2025: $7.70MQ4 2025: $25.9MQ1 2026: $15.8MQ2 2026: $17.4M
Institutions holding GANX and their total value by quarter
QuarterHoldersValue
Q2 202650$17.4M
Q1 202642$15.8M
Q4 202548$25.9M
Q3 202538$7.70M
Q2 202535$6.49M
Q1 202533$5.07M
Q4 202425$3.94M
Q3 202419$2.40M
Q2 202428$3.89M
Q1 202426$7.04M
Q4 202324$5.05M
Q3 202324$4.95M
Q2 202324$5.68M
Q1 202322$5.54M
Q4 202221$3.78M
Q3 202223$3.95M
Q2 202216$3.87M
Q1 202216$4.75M
Q4 202119$5.71M
Q3 202114$6.65M
Q2 202114$8.95M
Q1 202112$15.0M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Gain Therapeutics, Inc.; share changes are against Q4 2023.

Institutions holding GANX in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
DME Capital Management, LPSuperinvestorGreenlight Capital566,130$2.13M0.10%+566,130New
Raymond James & Associates260,019$980.3K0.00%+236,231+993.1%Added
Royal Bank of Canada248,500$937.0K0.00%+48,252+24.1%Added
Geode Capital Management, LLC177,091$667.7K0.00%+25,615+16.9%Added
Vanguard Group Inc119,364$450.0K0.00%+30,979+35.1%Added
CM Management, LLC90,000$339.3K0.28%00.0%Unchanged
BlackRock Inc.75,398$284.3K0.00%+47,787+173.1%Added
Renaissance Technologies LLC46,700$176.0K0.00%+3,900+9.1%Added
Northern Trust Corp46,486$175.3K0.00%+2,973+6.8%Added
Millennium Management LLC44,416$167.4K0.00%+31,652+248.0%Added
Susquehanna International Group, LLP43,062$162.3K0.00%+8,562+24.8%Added
Prelude Capital Management, LLC35,820$135.0K0.01%−22,280−38.3%Reduced
State Street Corp30,837$116.3K0.00%+30,837New
Bridgeway Capital Management, LLC30,000$113.1K0.00%−16,100−34.9%Reduced
Simplex Trading, LLC17,983$67.0K0.00%+17,983New
UBS Group AG8,673$32.7K0.00%−5,350−38.2%Reduced
Tower Research Capital LLC (TRC)4,632$17.5K0.00%−260−5.3%Reduced
Creekmur Asset Management LLC4,440$16.7K0.01%00.0%Unchanged
Citadel Advisors LLC4,223$15.9K0.00%−61,171−93.5%Reduced
Wells Fargo & Company3,756$14.2K0.00%+29+0.8%Added
Bank of America Corp3,375$12.7K0.00%+3,375New
Morgan Stanley2,800$10.6K0.00%00.0%Unchanged
Group One Trading, L.P.2,001$7.54K0.00%−1,936−49.2%Reduced
HM Payson & Co1,000$3.77K0.00%00.0%Unchanged
Citigroup Inc684$2.58K0.00%+684New
GWM Advisors LLC225$8480.00%+225New
Dimensional Fund Advisors LP0$00.00%−15,886−100.0%Sold out
XTX Topco Ltd0$00.00%−11,453−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−10,000−100.0%Sold out
Greenlight Capital Inc––––Not filed